2024
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection.
Clever S., Limpinsel L., Meyer zu Natrup C., Schünemann L.-M., Beythien G., Rosiak M., Hülskötter K., Gregor K.M., Tuchel T., Kalodimou G., Freudenstein A., Kumar S., Baumgärtner W., Sutter G., Tscherne A., Volz A.
Viruses 2024 Mar 8;16(3):417. https://www.mdpi.com/1999-4915/16/3/417.
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection.
Kubinski M., Beicht J., Gerlach T., Aregay A., Osterhaus A.D.M.E., Tscherne A., Sutter G., Prajeeth C.K., Rimmelzwan G.F.
Vaccines. 2024; 12(1):105. doi: 10.3390/vaccines12010105.
Protective MVA-ST Vaccination Robustly Activates T Cells and Antibodies in na Aged-Hamster Model for COVID-19.
Clever S., Schünemann L.M., Armando F., Meyer Zu Natrup C., Tuchel T., Tscherne A., Ciurkiewicz M., Baumgärtner W., Sutter G., Volz A.
Vaccines (Basel). 2024 Jan 3;12(1):52. doi:10.3390/vaccines12010052. PMID: 38250865.